Exploiting the fact that the IL3 receptor is overexpressed in CML cells compared with normal cells, IL3-LAMP-2B-expressing exosomes specifically targeted cells. Here, IL3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.